Judeline Casimir: Preeclampsia Awareness Month – Moving From Knowing the Risks to Saving Lives
Judeline Casimir, CEO, Founder of Casimir Public Health Empowerment, shared a post on LinkedIn:
“May is Preeclampsia Awareness Month.
And this is one of the clearest examples of a larger issue in maternal health:
We know.
Preeclampsia affects 5–8% of pregnancies in the U.S.
- We know the symptoms.
- We know it can occur up to 6 weeks postpartum.
- We know Black women are at higher risk.
And yet outcomes are still inconsistent.
So the question is no longer:
- What do we need to know?
It’s:
Why isn’t what we already know working?
Because in many cases:
- Symptoms are dismissed
- Guidance is unclear
- Postpartum follow-up is inconsistent
And mothers are left navigating risk on their own.
This is the gap.
The space between clinical knowledge and real-world care delivery.
Awareness matters.
But outcomes change when systems are designed to respond in time.
If your organization is working to improve maternal outcomes, the next step is clear:
Identify where your system is failing to translate what it already knows.
Let’s fix that.”

Stay updated with Hemostasis Today.
-
Jun 6, 2026, 08:25Marina Tarunina: Engineered Platelets From Human iPSCs Support Haemostasis Without Thromboembolism
-
Jun 6, 2026, 08:21Razieh Parizad: Systematic Review Evaluates the Future Role of Factor XI Inhibitors in Stroke Prevention
-
Jun 6, 2026, 08:10Vrinda Trivedi: Hematologic Emergencies and Anticoagulation Strategies Spotlighted at CCCES 2026
-
Jun 6, 2026, 08:02Krisstina Gowin: Could the Gut Microbiome Be the Missing Link in Hematology Outcomes?
-
Jun 6, 2026, 07:59Razan Awan: Large Cohort Study Questions Routine Use of Dual Antiplatelet Therapy After TAVI
-
Jun 6, 2026, 07:28Ahmed Dheyaa Al-Obaidi: Retrospective Study Highlights the Role of Transient Elastography in Pediatric Hepatic Fibrosis
-
Jun 6, 2026, 06:55Valeria Galetti: Understanding the Root Causes of Anemia in Madagascar
-
Jun 6, 2026, 06:45Abdulrahman Al-Mashdali: Emerging Role of Anti-CD38 Therapy in ITP
-
Jun 6, 2026, 06:20Pedro Gaspar: The Role of CD4⁺ T Cells in APS